• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Measures Adopted by Public Health Agencies to Mitigate the Consequences of COVID-19

Share:

May 13, 2020

The number of people infected by COVID-19 worldwide is quickly moving toward 2 million and almost 33% of them are from the U.S. The circumstance is past dreary and administrative bodies in the U.S. are acting rapidly to contain the harm coming about because of the spread of this novel infection.

Starting with the entry restrictions, federal agencies and healthcare regulatory bodies have executed a few measures to ensure the wellbeing and interests of healthcare professionals, program planners, manufacturers, distributors and the overall population.

Flexibility and waivers granted to healthcare stakeholders

The new rules issued by the Centers for Medicare and Medicaid (CMS) state that healthcare providers will be permitted to manage increased patient volumes by utilizing remote triage capabilities. Suspected infected persons who have developed mild to moderate symptoms would be directed to designated inpatient rehabilitation hospitals, ambulatory surgery centers, and specially outfitted hotels and dormitories. This way, healthcare professionals will be able to better attend patients in critical conditions while ensuring all the protocols issued to contain the infection are maintained and personal protective equipment is conserved.

To manage the dearth of healthcare professionals against the growing patient volumes, local physicians and providers are also being encouraged to contribute to healthcare services. Certain rules also have been relaxed to make that happen. The new rule also states that physicians will receive resources to provide telehealth services along with other motivational perks such as childcare services and meals.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

For a certain period of time, CMS has issued some relief to healthcare providers from some administrative requirements. Healthcare professionals are working day in, day out, relentlessly, under immense pressure. The temporary flexibilities offered should provide some respite from organizational and regulatory requirements to healthcare providers.

Solution for the shortage of medical supplies

Currently, there is an acute lack of ventilators in the US healthcare system, which is necessary to treat the critically ill, infected patients. Unless a new supply source is discovered, the ventilator supply will dry up soon. In that case, adding new ventilators would become very expensive. It will cost an additional $12000 to add one ventilator.

A private ventilator manufacturing company, Respironics Inc, has pledged to deliver 2,000 ventilators a week by May end. However, the current condition is critical and the Trump administration requires them to deliver 100,000 ventilators in 100 days. Under the Defense Production Act, Respironics has been ordered to boost its production and meet the growing demand.

The Food and Drug Administration (FDA) has also offered help to manage the ventilator shortage. The ventilators used in ambulances and anesthesia gas machines will now be used by hospitals. The FDA has also permitted the use of adapted nightstand CPAP machines, typically used for patients with sleep apnea.

There is also a huge shortage of medical gowns, masks and other basic supplies necessary for healthcare services. China was the major producer of these goods in the past; however, it’s not exporting them in full capacity anywhere currently. CDC has advised using homemade masks and bandanas until the medical supplies are available again. Hospitals are also gathering volunteers to sew masks for healthcare workers.

Safeguarding the interests distributors, manufactures and program planners

Under the 2005 Public Readiness and Emergency Preparedness (PREP) Act, companies will receive protection from the damaging effects of the countermeasures against COVID-19. Manufacturers, distributors and program planners suffering losses due to medical and security countermeasures will be covered. The drugs and devices used to treat and prevent the spread of the novel coronavirus will be included in these countermeasures.

Mitigating the consequential financial crisis

The pandemic will likely snowball into a global economic crisis. It is being speculated that it will be worse than the 2007-2008 recession. As a precautionary measure, the Federal Reserve has decided to add $1.5 trillion into the financial system. The student loan borrowers will also receive some temporary concessions. The interests shall be waived until the pandemic subsides. The administration has also passed a $100 billion relief plan to increase paid leave for workers and has expanded the scope of unemployment insurance and COVID-19 testing.

The road ahead

The federal government is coming up with new measures to reduce the possible consequences of this public health and economic crisis. However, the COVID-19 pandemic is unlike anything the healthcare and other sectors have ever been through, in recent years.

There aren’t sufficient healthcare resources and if the number of infected people increases, the pressure would increase even further. Following the rules and advice issued by the regulatory bodies and practicing social distancing to prevent the spread of this disease is extremely important, especially now.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Global Alzheimers Disease Diagnostics and Therapeutics Market Size to Grow USD 21704.4 Million By 2030 | CAGR of 5.5%Global Alzheimers Disease Diagnostics and Therapeutics Market Size to Grow USD 21704.4 Million By 2030 | CAGR of 5.5%
  • State of Consumerism in Healthcare 2021: Regaining MomentumState of Consumerism in Healthcare 2021: Regaining Momentum
  • Philips and NYU Langone Health Forge 8-Year, $115 Million Partnership to Elevate Patient Care through InnovationPhilips and NYU Langone Health Forge 8-Year, $115 Million Partnership to Elevate Patient Care through Innovation
  • Bringing the Customer Voice to Life in HealthcareBringing the Customer Voice to Life in Healthcare
  • Medtronic CEO points to M&A ‘firepower,’ new products as diabetes sales dropMedtronic CEO points to M&A ‘firepower,’ new products as diabetes sales drop
  • Verily Study Watch Picks up New 510(k) for Irregular Pulse MonitoringVerily Study Watch Picks up New 510(k) for Irregular Pulse Monitoring
  • Quantum Announces Agreement to Acquire Western Digital’s ActiveScale BusinessQuantum Announces Agreement to Acquire Western Digital’s ActiveScale Business
  • Johnson & Johnson acquires robotics company Auris HealthJohnson & Johnson acquires robotics company Auris Health

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications